Ivabradine
Corlanor
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
NADAC/unit
$0.8436
No Shortage
Tier 1: 49.2%
PA Req: 113.4%
6 Manufacturers
12 ANDAs
vs. brand Corlanor: Generic saves up to 92% per unit
Active Shortages
2026-03-24 Discontinuation of the manufacture of the drug product, Amgen Inc.
2026-03-24 Discontinuation of the manufacture of the drug product, Amgen Inc.
2026-03-24 Discontinuation of the manufacture of the drug product, Amgen Inc.
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAMGEN INCANNORA PHARMA PRIVATE LTDBIONPHARMA INCINGENUS PHARMACEUTICALS LLCMSN LABORATORIES PRIVATE LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.